Central-Nervous-System Toxoplasmosis in Homosexual Men and Parenteral Drug Abusers

  1. BRIAN WONG, M.D.;
  2. JONATHAN W. M. GOLD, M.D.;
  3. ARTHUR E. BROWN, M.D.;
  4. MICHAEL LANGE, M.D.;
  5. RICHARD FRIED, M.D.;
  6. MICHAEL GRIECO, M.D.;
  7. DONNA MILDVAN, M.D.;
  8. JOSÉ GIRON, M.D.;
  9. MICHAEL L. TAPPER, M.D.;
  10. CHESTER W. LERNER, M.D.; and
  11. DONALD ARMSTRONG, M.D.
  1. New York, New York

    Abstract

    Central-nervous-system toxoplasmosis developed in 7 of 269 patients with the acquired immunodeficiency syndrome reported to the New York City Health Department through July 1982. Focal neurologic abnormalities, mass lesions on computed-tomographic brain scans, lymphocytic cerebrospinal fluid pleocytosis, and detectable IgG antibody to Toxoplasma gondii were common; but IgG titers of 1:1024 or more, IgM antibody to T. gondii, and positive open brain biopsies were uncommon. Serologic findings suggested that the disease resulted from recrudescent rather than primary infection. Four of five patients improved when treated with sulfonamides and pyrimethamine, but 2 had relapses. An aggressive diagnostic approach and sometimes even empiric therapy are warranted when central-nervous-system toxoplasmosis is suspected in a seropositive patient with the acquired immunodeficiency syndrome.

    Article and Author Information

    • ▸From the Infectious Disease Services, Departments of Medicine, Memorial Sloan-Kettering Cancer Center; St. Lukes-Roosevelt Medical Center; Beth Israel Hospital; Queens Hospital Medical Center; and Lenox Hill Hospital; New York, New York.

    • Grant support: by the American Cancer Society Junior Faculty Clinical Fellowships 695A and 555A.

    • ▸Requests for reprints should be addressed to Brian Wong, M.D.; Infectious Diseases Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue; New York, NY 10021.

    « Previous | Next Article »Table of Contents